Search

everythinglearnresearchcommunity

for

Search:↓

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Testosterone and dihydrotestosterone can slow down the growth of certain hair follicle cells.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

New treatments for male hypogonadism are effective and should be personalized.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Most patients improved with oral contraceptives, but some needed additional treatment.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.